Funding of early fundamental and clinical research rarely comes from VC capital, since the probability for a positive ROI is quite low.

This is why early research is mostly funded by governments. Sadly, a lot of conditions are not properly researched due to lack of funding. Some governments are better at distributing funds than others. The current US administration isn’t.